If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
193.10    -0.10 (-0.05%)
Bid:
191.40
Ask:
191.60
Spread: 0.20 (0.104%)
Market Cap: £1.94b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Ordinary General Meeting

2 Aug 2018 07:00

RNS Number : 5126W
B&M European Value Retail S.A.
02 August 2018
 

 

 

02 August 2018

 

B&M European Value Retail S.A.

 

Notice of Ordinary General Meeting

 

B&M European Value Retail S.A. (the "Company"), the UK's leading general merchandise value retailer, announces that it has posted to shareholders today Notice of an Ordinary General Meeting of the Company.

 

The Ordinary General Meeting will be held at on Tuesday 18 September 2018 at Le Royal Hotel, 12, Boulevard Royal, L-2449 Luxembourg, commencing at 10:00 am (CET).

 

The purpose of the Ordinary General Meeting is to propose that Tiffany Hall be appointed as a Non-Executive Director of the Company.

 

The Notice of the Ordinary General Meeting, is available on the Company's website at www.bandmretail.com/investors/ogm.aspx

 

A summary form of the Notice of the Ordinary General Meeting is set out in Appendix 1 to this announcement.

 

 

Enquiries

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive

Paul McDonald, Chief Financial Officer

investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Daniel Yea

bmstores-maitland@maitland.co.uk

 

 

 

APPENDIX 1

 

B&M European Value Retail S.A.

Société Anonyme

Registered office: 9, Allée Scheffer, L-2520 Luxembourg

Grand-Duchy of Luxembourg

R.C.S. Luxembourg: B 187275

 

Notice of the Ordinary General Meeting of B&M European Value Retail S.A. to be held at 10:00 am (CET) on Tuesday 18 September 2018 at Le Royal Hotel, 12, Boulevard Royal, L-2449 Luxembourg.

 

AGENDA

1. To appoint Tiffany Hall as a Director of the Company with immediate effect until the Annual General Meeting resolving on the financial statements for the financial year ended 31 March 2019.

 

Explanation of Business to be considered at the Extraordinary General Meeting

 

Resolution: Appointment of Non-Executive Director

The Board of Directors (the "Board") of B&M European Value Retail S.A. ("B&M" or the "Company") presently has seven members, comprising the Non-Executive Chairman, two Executive Directors and four Independent Non-Executive Directors. As the business in the Company's group continues to grow at a significant rate and also as part of succession planning generally looking to the future, the Board considers that there is a requirement for further non-executive director appointments to be made in the meantime.

 

Following a search undertaken by Russell Reynolds Associates on behalf of the Nomination Committee of the Company and a series of interviews, the Nomination Committee has recommended that Tiffany Hall be appointed as a Non-Executive Director to the Board of B&M. The Board has unanimously resolved to propose that Tiffany be appointed with immediate effect to the Board by the ordinary general meeting of shareholders of the Company.

 

Tiffany Hall has a strong background in marketing, sales and customer services. She previously served as Managing Director of BUPA Home Healthcare, Marketing Director at BUPA, Head of Marketing at British Airways and also Chair of Airmiles and BA Holidays. Prior to that she held other positions at British Airways including Head of Global Sales and Distribution and Head of UK Sales and Marketing. She has also previously been a Non-Executive Director of Think London.

 

Tiffany is currently the Senior Independent Director and Chair of the Remuneration Committee of Howden Joinery Group Plc ("Howden"). She originally joined the Board of Howden as a Non-Executive Director in May 2010.

 

Notes 

 

Quorum and voting

In accordance with Article 24.6 of the Articles of Association of the Company, all decisions taken at the Meeting will be passed by a simple majority of the votes cast on the resolution, regardless of the proportion of issued ordinary share capital represented by shareholders at the Meeting. Each holder of ordinary shares has one vote in respect of each ordinary share held. As a result, the quorum for the Meeting is at least one shareholder present in person or by proxy.

 

Total voting rights

As at 1 August 2018 (being the last business day prior to the publication of this notice) the Company's issued ordinary share capital consists of 1,000,561,222 (one billion five hundred and sixty-one thousand two hundred and twenty two) ordinary shares, carrying one vote each. The Company holds no treasury shares, therefore the total voting rights in the Company as at 1 August 2018 is 1,000,561,222 (one billion five hundred and sixty-one thousand two hundred and twenty two).

 

Poll

All items in the Notice of the Ordinary General Meeting will be decided by a poll of shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGGMGGRFMVGRZM
Date   Source Headline
11th Sep 202511:00 amRNSCEO Purchase of Shares
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20254:00 pmRNSTotal Voting Rights
20th Aug 20259:00 amRNSDirector/PDMR Shareholding
14th Aug 20255:30 pmRNSDirector/PDMR Exercise of Share Options
1st Aug 202510:00 amRNSDirector/PDMR Shareholding
30th Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jul 20259:01 amRNSResult of EGM
23rd Jul 20259:00 amRNSResult of AGM 22 July 2025
22nd Jul 20254:00 pmRNSTR1 Major Shareholdings in Company
21st Jul 20258:00 amRNSBlock Listing Application
16th Jul 20256:00 pmRNSTR1: Major Shareholding Notification
15th Jul 20257:00 amRNSPositive Quarterly LFL Trading Performance
14th Jul 20255:30 pmRNSBlock Listing Six Monthly Return
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
27th Jun 202511:00 amRNSTR1: Major Holdings in Company
24th Jun 202510:00 amRNSNotice of FY26 Q1 Trading Statement
19th Jun 20254:30 pmRNSDirector Purchase of Shares
19th Jun 20257:00 amRNSNotice of EGM to approve Migration
19th Jun 20257:00 amRNSPublication of Annual Report and Notice of AGM
17th Jun 20257:00 amRNSCEO Purchase of Shares
12th Jun 20255:00 pmRNSDirector/PDMR Purchase of Shares
12th Jun 202510:30 amRNSDirector Share Options
4th Jun 20257:00 amRNSFY25 Preliminary Results
2nd Jun 20256:24 pmRNSTotal Voting Rights
19th May 20255:30 pmRNSTR1: Major Holdings in Company
15th May 20257:00 amRNSAppointment of Tjeerd Jegen as CEO
30th Apr 20257:00 amRNSDirectorate Change
15th Apr 20257:00 amRNSFY25 Post Close Trading Statement
11th Apr 20259:00 amRNSTR1- Major Shareholding Notification
8th Apr 202511:15 amRNSTR1- Major Shareholding Notification
3rd Apr 20256:15 pmRNSTotal Voting Rights - Correction
1st Apr 202512:30 pmRNSTotal Voting Rights
27th Mar 20254:00 pmRNSTR1 - Major Shareholding Notification
24th Mar 202512:00 pmRNSNotice of FY25 Post Close Trading Statement
27th Feb 20257:45 amRNSDirector/PDMR Purchase of Shares
24th Feb 20257:00 amRNSDirectorate Change and Update on FY25 Guidance
19th Feb 20259:00 amRNSTR1 Major Shareholding Notification
7th Feb 20259:00 amRNSTR1 Major Shareholding Notification
3rd Feb 20255:00 pmRNSTR1 Major Shareholding Notification
30th Jan 20255:30 pmRNSTR1 Major Shareholding Notification
24th Jan 202511:00 amRNSTR1 Major Shareholding Notification
20th Jan 202510:45 amRNSResult of OGM
14th Jan 20255:33 pmRNSBlock Listing Six Monthly Return
13th Jan 20254:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS3rd Quarter Trading Update
18th Dec 20248:31 amRNSNotice of Ordinary General Meeting
17th Dec 20249:15 amRNSBoard Appointment
10th Dec 202410:30 amRNSTiming of Announcement of Q3 Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.